# Northwell Ventures

> Northwell Ventures is a VC fund backing Health Care and Medical. See 27 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: New Hyde Park, United States
- Total investments: 27
- Last investment: Jul 2024
- Lead investor: 48%
- Last updated: Aug 2026
- Website: https://www.northwell.edu/about/our-organization/northwell-ventures

Northwell Ventures is a VC fund in New Hyde Park focused on Health Care and Medical. Northwell Ventures was launched to advance medical technology and promote the development of Northwell Health enterprises.

## Contacts

5 contacts available for Northwell Ventures. Shizune tracks 7 team members at Northwell Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/northwell-ventures?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 13 | 48% |
| Medical | 6 | 22% |
| Software | 5 | 19% |
| mHealth | 4 | 15% |
| Medical Device | 4 | 15% |

28 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Funding Round | 5 | 19% |
| Series B | 4 | 15% |
| Seed | 3 | 11% |
| Series A | 3 | 11% |
| Venture - Series Unknown | 2 | 7% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 13 | 48% |
| Ireland | 1 | 4% |
| Singapore | 1 | 4% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Emily Kagan Trenchard | Vice President, Digital and Innovation Strategy | 0 | https://shizune.co/investors/profile/emily-kagan-trenchard |
| Sean Dowling | Managing Director | 0 | https://shizune.co/investors/profile/sean-dowling-868a |
| Thomas Thornton | Senior Vice President | 0 | https://shizune.co/investors/profile/thomas-thornton |
| Tom Thornton | SVP of Ventures | 1 | https://shizune.co/investors/profile/tom-thornton-2 |
| Winston Rodriguez | Venture Capital & Corporate Development | 0 | https://shizune.co/investors/profile/winston-rodriguez |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Clarapath | Clarapath is a medical robotics company automating the laboratory. The company's first product is focused on fully automating the microtomy station in pathology. Their vision is to innovate, standardize, and digitally transform anatomic pathology through higher-quality lab medicine, more robust safety standards, and increased lab throughputwhile lowering laboratory costs and labor-related delays.Their next-generation laboratory at the NY Genome Center together with our large-scale image repository and analysis platform are designed to handle the entire “tissue to bits” pipeline for special research projects as well as larger-scale clinical needs. Clarapath works closely with both research and clinical customers to produce faster, more accurate results. | $36M | Series B | Jul 24, 2024 |  |
| Clarapath | Clarapath is a medical robotics company automating the laboratory. The company's first product is focused on fully automating the microtomy station in pathology. Their vision is to innovate, standardize, and digitally transform anatomic pathology through higher-quality lab medicine, more robust safety standards, and increased lab throughputwhile lowering laboratory costs and labor-related delays.Their next-generation laboratory at the NY Genome Center together with our large-scale image repository and analysis platform are designed to handle the entire “tissue to bits” pipeline for special research projects as well as larger-scale clinical needs. Clarapath works closely with both research and clinical customers to produce faster, more accurate results. | $36M | Series B | Jul 24, 2024 |  |
| Holmusk | Holmusk is developing a Real-World Evidence platform in behavioral health and chronic diseases to expand data-driven, evidence-based care for people managing behavioral health conditions. It works by bringing together specialty behavioral health data and Holmusk’s novel analytics platform to deliver evidence-based insight that can be used to maketreatment decisions, as well as the commercialization of new drugs.Holmusk was founded in 2015 and is based in Singapore, Malaysia, and the USA. | $45M | Series B | Jan 09, 2023 |  |
| Playback Health, Inc. | Playback Health is an AI software technology company that builds and deploys secure mobile solutions to help providers more effectively deliver medical information and care instructions to patients, their families, and other care providers. Its SaaS platform helps promote a "Communication-First" strategy that allows healthcareorganizations to leverage their EMRs, patient portals, and other systems using automation and conversational intelligence and AI to save clinicians hours each day and deliver massive HCAHPS improvements for providers. Playback Health's SOC2 certified architecture allows any API-enabled organization or platform to securely connect to the point of care to bring patient data and services to life, wherever the patient's care journey may go. Playback is deployed in 30 hospitals and care organizations across the United States. | $1.8M | Seed | Sep 12, 2022 |  |
| Violet | Violet is a platform that helps the healthcare industry deliver more inclusive services. It enables identity-centered care for everyone. | $4.1M | Seed | Aug 15, 2022 |  |
| Nova Leah | Nova Leah believe in excellence through knowledge development, sharing and collaboration to enhance the security assurance of medical devices. Nova Leah's product, SelectEvidence, is an intelligent cybersecurity risk management compliance solution aimed at medical device manufacturers and healthcare providers. |  | Venture - Series Unknown | Dec 07, 2021 |  |
| Holmusk | Holmusk is developing a Real-World Evidence platform in behavioral health and chronic diseases to expand data-driven, evidence-based care for people managing behavioral health conditions. It works by bringing together specialty behavioral health data and Holmusk’s novel analytics platform to deliver evidence-based insight that can be used to maketreatment decisions, as well as the commercialization of new drugs.Holmusk was founded in 2015 and is based in Singapore, Malaysia, and the USA. |  | Venture - Series Unknown | Dec 06, 2021 |  |
| Clarapath | Clarapath is a medical robotics company automating the laboratory. The company's first product is focused on fully automating the microtomy station in pathology. Their vision is to innovate, standardize, and digitally transform anatomic pathology through higher-quality lab medicine, more robust safety standards, and increased lab throughputwhile lowering laboratory costs and labor-related delays.Their next-generation laboratory at the NY Genome Center together with our large-scale image repository and analysis platform are designed to handle the entire “tissue to bits” pipeline for special research projects as well as larger-scale clinical needs. Clarapath works closely with both research and clinical customers to produce faster, more accurate results. | $16M | Series B | Nov 17, 2021 |  |
| Clarapath | Clarapath is a medical robotics company automating the laboratory. The company's first product is focused on fully automating the microtomy station in pathology. Their vision is to innovate, standardize, and digitally transform anatomic pathology through higher-quality lab medicine, more robust safety standards, and increased lab throughputwhile lowering laboratory costs and labor-related delays.Their next-generation laboratory at the NY Genome Center together with our large-scale image repository and analysis platform are designed to handle the entire “tissue to bits” pipeline for special research projects as well as larger-scale clinical needs. Clarapath works closely with both research and clinical customers to produce faster, more accurate results. | $16M | Series B | Nov 17, 2021 |  |
| Cognixion | Cognixion is a computer software company that specializes in the fields of artificial intelligence, machine learning, and biotechnology. It features a sensory communication system that enables people to communicate using a brain-computer interface that translates brainwaves directly into communication.The company was founded in 2014 andheadquartered in Santa Barbara, California. | $12M | Seed | Nov 16, 2021 |  |

10 of 27 investments shown.

## Co-investors
- [Builders VC](https://shizune.co/investors/profile/builders) — VC Fund, 8 deals together
- [P5 Health Ventures](https://shizune.co/investors/profile/p5-health-ventures) — VC Fund, 6 deals together
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund, 4 deals together
- [Genesis Merchant Capital](https://shizune.co/investors/profile/genesis-merchant-capital) — VC Fund, 4 deals together
- [J-Ventures](https://shizune.co/investors/profile/j-ventures-f370) — VC Fund, 4 deals together
- [Nassau Street Ventures](https://shizune.co/investors/profile/nassau-street-ventures) — VC Fund, 4 deals together

## Similar investors

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

## FAQ

### What does Northwell Ventures invest in?

Northwell Ventures invests primarily in Health Care, Medical and Software startups, most often at Funding Round and Series B stage. Most of the 27 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Northwell Ventures?

Public channels for Northwell Ventures include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Northwell Ventures?

The team at Northwell Ventures includes Emily Kagan Trenchard (Vice President, Digital and Innovation Strategy), Sean Dowling (Managing Director) and Thomas Thornton (Senior Vice President), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co